Brigatinib/Brigatinib Dosage and Usage

Brigatinib/Brigatinib (Brigatinib) is an oral drug used to treat non-small cell lung cancer (NSCLC). Before using brigatinib/brigatinib it is important to understand the correct dosage, drug interactions, and information about use in special populations. These aspects are described in detail below.

Dosage and usage:

1.The generally recommended dose is once a day, taken orally.

2.It is recommended to take Brigatinib/Brigatinib after meals.

3.Brigatinib/Brigatinibtablets are generally available in 90 mg (mg) and 180 Milligram (mg) is available in two specifications.

4.At the beginning of treatment, a dose of 90 mg (mg) is usually used, and the doctor may gradually adjust the dose based on the patient's tolerance and needs.

5.Patients should follow the doctor's instructions, take medication according to the prescribed dosage and usage, and have regular follow-up visits and monitoring.

Drug interactions:

1.Brigatinib/Brigatinib may interact with other drugs, affecting their efficacy or increasing the risk of adverse reactions. In useBrigatinib/BrigatinibBeforehand, inform your doctor about all medications, supplements, and herbal products you are using.

2.Brigatinib/Brigatinibmay interact with CYP3A Enzyme inhibitors (such as crizotinib, itidacan) or inducers (such as phentolamine) interact, thereby affecting the metabolism and efficacy of brigatinib/brigatinib.

3.Brigatinib/Brigatinib may also interact with other drugs, such as antifungal drugs, antibiotics, heart drugs, anti-epileptic drugs, etc.

4.During the use of brigatinib/brigatinib, drug interactions and side effects should be closely monitored, and adjustments and management should be made according to the doctor's recommendations.

Medicine for special groups:

1.Elderly patients: Elderly patients may require special attention when using brigatinib/brigatinib as they may be more susceptible to drug-related adverse reactions. Your doctor may adjust the dose or monitor drug tolerability at your doctor's discretion.

2.Patients with Hepatic Impairment: For patients with mild to moderate hepatic impairment, dose adjustment may be necessary. However, the safety and efficacy of brigatinib in patients with severe hepatic impairment are unclear and its use is not recommended.

3.Patients with impaired renal function: Brigatinib/Brigatinib Dosage recommendations in patients with impaired renal function are unclear. Currently usingbrigatinib/BrigatinibBefore taking brigatinib, you should consult your doctor to learn about the best medication regimen for your patient.

4.Pregnant and lactating women:Brigatinib/Brigatinib may cause damage to the fetus and is not recommended for use during pregnancy. Breastfeeding women should also stop breastfeeding to avoid passing the drug to the baby through breast milk.

It should be emphasized that the above is a general guide only and does not apply to every patient. Before using brigatinib/brigatinib, you should consult a professional doctor or pharmacist to obtain individualized medication recommendations, and follow the doctor's instructions for medication.

In summary, Brigatinib/Brigatinib is taken orally once a day after meals. Before using brigatinib/brigatinib you should tell your doctor about the medications and supplements you are using to avoid drug interactions. Special populations, such as elderly patients, patients with impaired liver function, and pregnant and lactating women, may require special attention and medication adjustments. During the use of brigatinib/brigatinib, you should have regular follow-up visits and monitoring, and work closely with your doctor to ensure safe and effective treatment.

Brigatinib/Brigatinib has been launched in China and has been included in medical insurance. Since it has just been approved for marketing, patients may not be able to buy it in domestic pharmacies. If you need to purchase it in China, please consult the local pharmacy. However, the price is quite high, more than 10,000 yuan. Foreign Brigatinib/Brigatinib are mainly generic drugs, mainly Bangladeshi and Laos generic drugs. The price of the international version of the Bangladeshi generic drug Yaopin is about 2000yuan, the specification is 90mg*30 tablets; the price of the Laos version of the generic drug is about 600, and the specification is smaller. And the ingredients of domestic original drugs and foreign generic drugs are basically the same.